Staphylococcus aureus vs. Osteoblast: Relationship and Consequences in Osteomyelitis by Jérôme Josse et al.
REVIEW
published: 26 November 2015
doi: 10.3389/fcimb.2015.00085
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 1 November 2015 | Volume 5 | Article 85
Edited by:
Francois Vandenesch,
University of Lyon, France
Reviewed by:
Silvia T. Cardona,
University of Manitoba, Canada
Sophie Assant,
Centre International de Recherche en
Infectiologie, France
*Correspondence:
Sophie C. Gangloff
sophie.gangloff@univ-reims.fr
Received: 17 September 2015
Accepted: 10 November 2015
Published: 26 November 2015
Citation:
Josse J, Velard F and Gangloff SC
(2015) Staphylococcus aureus vs.
Osteoblast: Relationship and
Consequences in Osteomyelitis.
Front. Cell. Infect. Microbiol. 5:85.
doi: 10.3389/fcimb.2015.00085
Staphylococcus aureus vs.
Osteoblast: Relationship and
Consequences in Osteomyelitis
Jérôme Josse, Frédéric Velard and Sophie C. Gangloff *
EA 4691 Biomatériaux et inflammation en site osseux, Pôle Santé, Université de Reims Champagne-Ardenne, Reims, France
Bone cells, namely osteoblasts and osteoclasts work in concert and are responsible for
bone extracellular matrix formation and resorption. This homeostasis is, in part, altered
during infections by Staphylococcus aureus through the induction of various responses
from the osteoblasts. This includes the over-production of chemokines, cytokines and
growth factors, thus suggesting a role for these cells in both innate and adaptive
immunity. S. aureus decreases the activity and viability of osteoblasts, by induction
of apoptosis-dependent and independent mechanisms. The tight relationship between
osteoclasts and osteoblasts is also modulated by S. aureus infection. The present
review provides a survey of the relevant literature discussing the important aspects of
S. aureus and osteoblast interaction as well as the ability for antimicrobial peptides to
kill intra-osteoblastic S. aureus, hence emphasizing the necessity for new anti-infectious
therapeutics.
Keywords: Staphylococcus aureus, osteoblast, internalization, inflammation, antibiotics, antimicrobial peptide,
phenol soluble modulin, small colony variants
INTRODUCTION
Bone is quantitatively the most abundant mineralized tissue in humans. It is composed of cells
evolving in a tangle of collagen and non-collagenous proteins, which can be mineralized to form
the bone extracellular matrix (BEM). Osteoblasts are the bone forming cells. First, osteoblasts
synthesize an organic matrix around themselves and mineralize it to create the mature BEM
(Ecarot-Charrier et al., 1983) where they are ultimately integrated as osteocytes (Dallas and
Bonewald, 2010). The synthesis of the BEM is balanced by a resorption performed by osteoclasts.
Rising from the fusion of monocytic precursors to form giant multinuclear cells, osteoclasts secrete
H+ protons and several proteases to resorb both inorganic and organic parts of the BEM (Edwards
andMundy, 2011). The concomitant bone formation and resorption create perpetual physiological
homeostasis.
Osteoblast activity is altered in pathological conditions such as cancers, autoimmune diseases
and infections. Osteomyelitis are damaging bone infections, that can lead to sequelae and
if uncontrolled, to patients death. During childhood, osteomyelitis are mostly a result of
Abbreviations: S. aureus, Staphylococcus aureus; BEM, bone extracellular matrix; AMP, antimicrobial peptide; MSCRAMM,
microbial surface components recognizing adhesive matrix molecule; PAMP, pathogen-associated molecular pattern; PRR,
pattern recognition receptor; NOD, nucleotide-binding oligomerization domain; NLR, NOD like receptor; TLR, toll like
receptor; TNFR-1, tumor necrosis factor receptor 1; TNF-α, tumor necrosis factor α; NF-κB, nuclear factor kappa B; MHC,
major histocompatibility complex; RANK-L, receptor activator of NF-κB ligand; OPG, osteoprotegerin; TRAIL, tumor
necrosis factor-related apoptosis-inducing ligand; DR, death receptor; PGE2, prostaglandin E2; HBD, human β-defensin;
MBD, mouse β-defensin.
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hematogenous spread from distant infected tissues. In adults,
surgical procedures are becoming increasingly responsible for
a direct contamination of bone tissue, especially in presence
of medical devices (Montanaro et al., 2011). The incidence of
osteomyelitis varies from 1 to 55% in open fracture cases as
a function of the grade of the fracture (Kim and Leopold,
2012; Hogan et al., 2013). Germ concentration, pathogenicity
of the implicated pathogen or systemic factors such as nicotine,
obesity or diabetes mellitus can also favor the prognosis of
direct osteomyelitis (Hogan et al., 2013). Osteomyelitis are
typically of bacterial origin, notably Staphylococcus species, where
Staphylococcus aureus is the most prevalent pathogen (Lew and
Waldvogel, 2004), also responsible for various community or
hospital-acquired infections like skin abscess, pneumonia or
septic arthritis (Lowy, 1998).
Infection of osteoblasts by S. aureus is a keystone, a
determining element in the development of osteomyelitis in bone
tissue and as such this review focuses on the interaction between
S. aureus and the osteoblasts that play an important role in
bone homeostasis. S. aureus directly interacts with osteoblasts
both in the extracellular and intracellular space following its
internalization (Hudson et al., 1995). Each interaction specifically
leads to the induction of various and distinct responses from the
osteoblasts.
S. aureus possesses on its surface an arsenal of pathogen-
associated molecular patterns (PAMP) that interact with
osteoblasts to induce the production of chemokines and
cytokines that then recruit and activate innate and adaptive
immune cells (Heilmann, 2011; Claro et al., 2013). In addition
to inflammatory response, S. aureus can also induce the death of
osteoblasts and increase osteoclastogenesis through osteoblasts
stimulation thus resulting in an imbalanced bone homeostasis
(Tucker et al., 2000;Widaa et al., 2012). The combination of these
effects leads to inflammatory bone loss.
Recent studies have consequently focused on antibiotics
and their ability to kill intracellular S. aureus as well as
on antimicrobial peptides (AMP) that can be produced by
osteoblasts (Varoga et al., 2009; Zhu et al., 2014) or chemically
synthetized (Choe et al., 2015).
S. aureus embodies a major clinical challenge, as chronic
osteomyelitis with S. aureus are difficult to treat with antibiotics
(Spellberg and Lipsky, 2012). The ability of S. aureus to survive
in osteoblasts after internalization can protect it from immune
cells but also from the antibiotics that may not penetrate the cells
(Valour et al., 2015a).
We hereby provide an overview of the relationship and
interaction between S. aureus and osteoblasts, from the onset of
the infection to new therapeutics.
BONE EXTRACELLULAR MATRIX, A NICHE
FOR S. AUREUS
The capacity of S. aureus to infect bone—and more specifically
the osteoblast—is tightly correlated to its ability to bind the
BEM components, notably via multiple adhesins called the
MSCRAMMs which stands for microbial surface components
recognizing adhesive matrix molecules (Heilmann, 2011). The
proteins and glycans present in the BEM are all potential S. aureus
binding sites. The most studied of these are type I collagen, bone
sialoprotein, osteopontin, and fibronectin because they directly
interact with S. aureus (Figure 1).
Type I collagen represents approximately 90–95% of the
organic fraction of the BEM, thus supporting a major role for
the collagen adhesin (Cna) of S. aureus in the pathogenesis
of osteomyelitis. Cna has resulted in being pivotal for settling
osteomyelitis through hematogenous spread in a murine model
(Elasri et al., 2002). Cna is highly expressed during the stage of
exponential growth of S. aureus (Gillaspy et al., 1997) and Cna-
positive strains are often associated with a slime formation, a
state that enhances the pathogenicity of S. aureus in implant-
associated osteomyelitis (Montanaro et al., 1999).
The bone sialoprotein represents however another means
for S. aureus to bind the BEM. This protein constitutes
approximately 8% of all non-collagenous proteins found in bone
(Fisher et al., 1990). The bone sialoprotein binding protein (bbp)
is a member of the staphylococcal serine-aspartate dipeptide
repeat (sdr) family (Tung et al., 2000) and is one of the first
adhesins studied for its potential role in osteomyelitis caused by
S. aureus (Rydén et al., 1989). Bbp could be considered as an
adhesin with several ligands due to the recognition of fibrinogen
in a non-osseous context (Vazquez et al., 2011). The presence
of both cna and bbp genes in S. aureus is considered as a
major marker of virulence in isolates from implant-associated
osteomyelitis (Campoccia et al., 2009).
An involvement of S. aureus Map—a functional bacterial
analog to mammalian MHC class II molecules—in osteomyelitis
is also speculated in regard to its ability to bind recombinant
osteopontin (Jönsson et al., 1995). The ability of S. aureus to bind
to biological osteopontin has nevertheless not been reported yet.
Fibronectin is the most studied component of the extracellular
matrix in staphylococcal infection, especially in osteomyelitis.
Fibronectin acts as a bridge between S. aureus and the osteoblasts.
On the one hand, S. aureus holds two types of proteins that
can bind to fibronectin on its surface: the fibronectin binding
proteins A and B (FnBP A/B). On the other hand, fibronectin
connects to the osteoblasts through the α5β1 integrin. This
“fibronectin bridge” allows the attachment of S. aureus and also
favors its internalization by non-phagocytic cells like many cell
types (Dziewanowska et al., 1999; Peacock et al., 1999; Ahmed
et al., 2001; Kintarak et al., 2004).
BEM attachment represents a major step in osteomyelitis
onset as 10–60% of studied S. aureus clones express cna, bbp,
and fnbB genes and 100% express fnbA or clumping factor A
and B genes (Otsuka et al., 2006; Campoccia et al., 2009; Atshan
et al., 2012; Post et al., 2014). In specific osteomyelitis case, cna
and bbp genes were more frequently identified in non-implant
related infections than in implant-related infections (Post et al.,
2014). Of note, expression of cna gene is increased in methicillin
resistant clones compared with methicillin sensible ones (Atshan
et al., 2012). To illustrate this point, the combination of cna and
bbp genes characterizes ST30—a pandemic community-acquired
methicillin resistant S. aureus that causes osteomyelitis—(Otsuka
et al., 2006; Dhanoa et al., 2012).
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FIGURE 1 | Staphylococcus aureus interaction with BEM. Staphylococcus aureus can interact with the BEM to concentrate around osteoblasts. Collagen
adhesin (Cna) links with type I collagen, bone sialoprotein binding protein (Bbp) links with bone sialoprotein, MHC II analog protein (Map) can potentially link
osteopontin. Fibronectin binding proteins A and B (FnBP A/B) link with fibronectin and act as bridges between Staphylococcus aureus and osteoblasts through α5β1
integrin.
BEM is therefore an important actor in the first step of S.
aureus infection as it is produced by and connected to osteoblasts.
It allows the bacteria to bind and concentrate around osteoblasts,
particularly for staphylococcal clones possessing cna, bbp, and/or
fnbB genes.
INVASION/INTERNALIZATION OF S.
AUREUS INTO OSTEOBLASTS
Ogawa et al. were the first to report the capacity of endothelial
cells to “engulf” S. aureus (Ogawa et al., 1985). It has been
shown since this observation that S. aureus can adhere to and
invade cultured osteoblasts (Table 1), as well as osteoblasts and
osteocytes in vivo (Hudson et al., 1995; Reilly et al., 2000; Bosse
et al., 2005).
The ability of fibronectin to link with α5β1 integrin has
currently been considered as the most common pathway for the
internalization of S. aureus in endothelial cells and osteoblasts
(Figure 2). Though this mechanism is specific to S. aureus
(Khalil et al., 2007), deleting FnBP A/B in S. aureus does not
completely abrogate its internalization by osteoblasts, suggesting
the involvement of other mechanisms in this process (Ahmed
et al., 2001). Cna and Bbp actually favor the FnBP-mediated
internalization (Testoni et al., 2011) whereas other MSCRAMMs
of S. aureus are involved in integrin-mediated internalization
(Hirschhausen et al., 2010; Zapotoczna et al., 2013). Other BEM
components like collagen or bone sialoprotein, also bind to
multiple integrins supporting the possibility of still unknown
“MSCRAMM/BEM component/integrin” bridge systems to
initiate the internalization of S. aureus by osteoblasts (Grzesik
and Robey, 1994).
Independently of the extracellular events, the involvement of
the cytoskeletal elements, particularly actin microfilaments, has
been shown during the internalization of S. aureus (Ellington
et al., 1999; Jevon et al., 1999; Figure 2). In addition, the
internalization process of S. aureus can occur with dead bacteria
but not dead osteoblasts. This suggests that the internalization
process is more an active cellular mechanism rather than an
active bacterial mechanism (Hudson et al., 1995).
Internalization of S. aureus by osteoblasts is a key element in
the spreading of the infection. It allows S. aureus to persist inside
osteoblasts—protected from the immune system—and it gives to
S. aureus the opportunity to sustain the infection.
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TABLE 1 | Staphylococcus aureus internalization by cultured osteoblasts.
Cells Strains MOI Observations Author/Year
CECOs Lab - Adherence, internalization and intracellular survival of Staphylococcus aureus
inside osteoblasts
Hudson et al.,
1995
MC3T3-E1 UAMS-1 - Involvement of actin microfilaments, microtubules and clathrincoated pits in the
internalization of Staphylococcus aureus by osteoblasts
Ellington et al.,
1999
MG-63, NHOs Lab, Clinic 30:1 Role of cytoskeleton of osteoblasts, notably actin microfilaments, in
internalization of Staphylococcus aureus
Jevon et al., 1999
MG-63 Lab 300:1 Role of fibronectin binding proteins A/B (FnBP A/B) in the internalization of
Staphylococcus aureus in osteoblasts
Ahmed et al., 2001
NHOs UAMS-1 25:1,
75:1,
250:1
Release of intracellular Staphylococcus aureus by dead osteoblasts and ability to
re-infect new osteoblasts
Ellington et al.,
2003
MG-63 Lab 300:1 Correlation between SigB expression in Staphylococcus aureus and its capacity
for internalization inside osteoblasts
Nair et al., 2003
MG-63 Lab 50:1,
200:1,
500:1
Internalization of Staphylococcus aureus into osteoblasts through a fibronectin
bridge to integrin α5β1
Khalil et al., 2007
MG-63 Clinic - Synergistic role of Cna and Bbp adhesins in the initial adhesion of
Staphylococcus aureus to osteoblasts, favoring the subsequent
FnBPA-mediated internalization.
Testoni et al., 2011
pHOB Lab, Clinic 50:1 Staphylococcus aureus can persist within osteoblasts for several weeks.
Persistence induces bacterial phenotypic diversity, including SCV phenotypes,
accompanied by changes in virulence factor expression
Tuchscherr et al.,
2011
MG-63 Lab 10:1 Evidence of a trafficking of intracellular Staphylococcus aureus into the late
endosomal/lysosomal compartment in osteoblasts
Jauregui et al.,
2013
UMR-106 Lab 100:1,
500:1,
1000:1
Internalization and survival of Staphylococcus aureus within osteoblasts and
macrophages led to differential responses
Hamza and Li,
2014
pHOB Lab, Clinic 50:1 Chronic osteomyelitis isolates were characterized by a high host cell invasion
rate, low cytotoxicity and the ability to persist and adapt within osteoblasts
through SCVs formation
Kalinka et al., 2014
pHOB Lab, Clinic 50:1 Sigma Factor SigB is an essential factor that enables Staphylococcus aureus to
switch from the highly aggressive phenotype that settles an acute infection to a
silent SCV-phenotype that allows for long-term intracellular persistence
Tuchscherr et al.,
2015
pHOB Lab, Clinic 50:1 Staphylococcus aureus continuously upregulated the expression of SigB during
intracellular persistence. The increased SigB expression was accompanied by
upregulation of adhesins and downregulation of toxins, which are characteristic
for SCVs
Tuchscherr and
Löffler, 2015
MG-63 Clinic 100:1 Lack of delta-toxin production was significantly associated with osteomyelitis
chronicity, osteoblast invasion and biofilm formation
Valour et al.,
2015b
MOI, Multiplicity of infection (number of bacteria per cell); CECOs, Chick embryo calvarial osteoblasts; NHOs, Normal human osteoblasts; pHOB, Primary culture of human osteoblasts;
MC3T3-E1, Mouse calvaria cell line; MG-63, Human osteosarcoma cell line; UMR-106, Rat osteosarcoma cell line; Lab, Laboratory strains of Staphylococcus aureus (purchased from
ATCC, NCTC,. . . ); Clinic, Strain of Staphylococcus aureus isolated from osteomyelitic patients; UAMS-1, Most studied laboratory strain of Staphylococcus aureus in bone infection
model.
INTRACELLULAR S. AUREUS AND
PERSISTENCE INTO OSTEOBLASTS
S. aureus can be localized in vesicles once inside the osteoblasts
(Figure 2). A co-localization of fluorescent intracellular S. aureus
and a lysosomal-associated membrane marker highlighted the
trafficking of live bacteria into the late endosomal/lysosomal
vesicles in osteoblasts. This hints to suggest that S. aureus
survives inside the vesicles (Jauregui et al., 2013). Moreover, a
recent study shows that internalization of S. aureus is higher in
macrophages—a typical professional phagocytic cells—than in
osteoblasts whereas the percentage of intracellularly surviving S.
aureus was higher in osteoblasts than in macrophages (Hamza
and Li, 2014). As non-professional phagocytic cells, the lack of an
effective intracellular bacterial clearance program in osteoblasts
may allow S. aureus to survive longer inside the latter. The ability
to survive inside osteoblasts is nevertheless explained by the exit
of S. aureus from the vesicles and its release in the cytoplasm to
escape proteolytic activity of the lysosome.
There are several types of membrane-damaging factors such
as hemolysins, bi-component leukocidins and phenol soluble
modulins (PSM) among S. aureus arsenal of virulence factors
(reviewed by Vandenesch et al., 2012). These factors are involved
in the escape of S. aureus from intracellular vesicles.
PSMα—a member of the PSM family—has been observed to
favor the escape of S. aureus from vesicles to the cytoplasm in
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FIGURE 2 | Staphylococcus aureus signaling mechanism after contact and internalization by osteoblasts. After internalization, Staphylococcus aureus can
escape from vesicle, be disrupted from inside the vesicle or persist inside osteoblasts through a SCV phenotype. Staphylococcus aureus can also interact with
extracellular receptors TLR2 and TNFR-1 and with intracellular receptors TLR9 and NODs after its internalization into osteoblasts thanks to α5β1 integrin and actin
filaments.
different types of cell line (Grosz et al., 2014). In Hela cells, a
similar mechanism of vesicular escaping has been also identified
for either PSMβ or δ-toxin. These two members of the PSM
family make the escape possible from the vesicles in synergy with
β-toxin (Giese et al., 2011).
PSMα has been shown to mediate the cytotoxicity for
intracellular S. aureus in osteoblast/S. aureus specific interaction
(Cassat et al., 2013; Rasigade et al., 2013). Valour et al. more
recently demonstrated that lack of δ-toxin in clinical isolates
from S. aureus bone and joint infections was correlated with the
chronicity of the infection (Valour et al., 2015b).
A tight relationship exists between vesicular escape, cytoxicity,
and membrane-damaging virulence factors. We can easily
assume that PSMs allow the escape from the vesicle and then
acts on the cell membrane so as jeopardize osteoblasts. This
phenomenon needs some investigations with regards to the S.
aureus/osteoblast interaction.
In addition to the vesicular escape, intracellular persistence
of S. aureus inside osteoblasts is also supported by the presence
of small colony variants (SCV). SCVs are a slow-growing
subpopulation of bacteria with atypical colony morphology on
agar plates and unusual biochemical characteristics. SCVs consist
of higher capacities for intracellular persistence and are less
liable to antibiotics than their wild-type counterparts (Proctor
et al., 2006). Involvement of SCVs in intracellular persistence
might be due to a better susceptibility to host uptake and/or a
selection of SCVs due to intracellular environment properties
(Proctor et al., 2014). SCVs were observed in in vitro models
of osteoblast/S. aureus interaction (Valour et al., 2015a,b). A
high percentage of SCVs was correlated with less cytoxicity of
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osteoblasts in isolates from chronic osteomyelitis with S. aureus
(Kalinka et al., 2014). In this context, Sigma Factor SigB of
S. aureus was shown to be an essential factor that leads to S.
aureus to switch from the highly aggressive phenotype that settles
an acute infection to a silent SCV-phenotype that leads to a
long-term intracellular persistence (Tuchscherr et al., 2015). A
continuous upregulation of SigB expression during intracellular
persistence was correlated with the upregulation of adhesins
and downregulation of toxins, which are characteristic for SCVs
(Tuchscherr and Löﬄer, 2015). The impact of SigB in S. aureus
internalization by osteoblasts was already observed more than a
decade ago (Nair et al., 2003). Moreover, SCVs were observed to
rapidly revert to the fully virulent wild-type form when leaving
the intracellular location and infecting new cells (Tuchscherr
et al., 2011).
Membrane-damaging virulence factors and SCVs are major
parameters in intracellular persistence of S. aureus inside
osteoblasts. On the one hand, PSMs make the escape from the
intracellular vesicle to the cytoplasm easier but also increase the
osteoblast death. On the other hand, SCVs can easily persist
inside osteoblasts thanks to their lowered virulence factors.
RECEPTORS INVOLVED IN THE
INTERACTION BETWEEN S. AUREUS AND
OSTEOBLASTS
In addition to binding to the BEM, S. aureus can also directly
stimulate osteoblasts, mostly through its PAMPs, leading to
various cellular responses (summarized in Table 2). The PAMPs
can interact with the osteoblasts pattern recognition receptors
(PRR) such as Toll-like receptors (TLR) and nucleotide-binding
oligomerization domains (NOD) like receptors (NLR), as well as
with the tumor necrosis factor receptor 1 (TNFR-1; Figure 2).
TLR is a family of thirteen membrane-bound PRRs that can
interact with different bacterial components (Kawai and Akira,
2010). TLR-2, TLR-4, TLR-5, and TLR-9 have been observed in
osteoblasts. TLR-2 is an extracellular receptor that can recognize
the PAMPs from S. aureus (Fournier, 2012). It induces the release
of AMPs as well as the induction of osteoblast apoptosis following
its activation by S. aureus (Varoga et al., 2009; Chen et al., 2014).
TLR-4 and TLR-5 take part in responses toward Gram negative
bacteria, by respectively recognizing LPS and flagellin but are not
involved in S. aureus/osteoblast interaction (Kikuchi et al., 2001;
Madrazo et al., 2003).
As opposed to TLRs −2, −4, and −5, TLR-9 is an
intracellular member of the TLR family. It is bound to the
membrane of intracellular vesicle. TLR-9 recognizes the CpG
oligodesoxynucleotides of bacterial DNA and is able to detect the
presence of S. aureus DNA (Zou et al., 2003). This can however
occur but after the disruption or disintegration of S. aureus
within the intracellular vesicles, leading to the release of its DNA
that then binds to TLR-9 and induces the activation of signaling
cascades (Wolf et al., 2011; Figure 2).
As above mentioned, intracellular S. aureus can also escape
from a vesicle and be released into the cytosol of osteoblasts
following its internalization. S. aureus can induce in this case
a response through the NLRs, a family of 22 intracellular
PRRs (Figure 2), NOD1, NOD2, NLRP3, and NLRC4 have been
studied in osteoblasts among the latter family. Over-expression
of NOD1 and NOD2 was assessed in osteoblasts infected by
intracellular S. aureus and led intracellular signaling to be
activated and to the production of immune molecules (Marriott
et al., 2005). Another study focusing onNOD2 backs the idea that
this NLR may serve differential roles in osteoblasts, promoting
inflammatory responses to invasive bacteria while tempering cell
responses to extracellular and/or passively internalized bacterial
species, such as S. aureus (Chauhan and Marriott, 2010). Two
other NLRs, NLRP3, and NLRC4, were also evidenced in
osteoblasts. NLRP3 is expressed in osteoblasts whereas NLRC4
expression was not found. The role of NLRP3 in bacteria-related
osteoblast death was studied for the invasive bacteria Salmonella
enterica but not for S. aureus (McCall et al., 2008).
It has been recently reported that S. aureus can also
interact through the extracellular TNFR-1 on epithelial cells and
osteoblasts independently from PRRs such as TLRs and NLRs
(Gómez et al., 2004; Claro et al., 2013). Originally described as
an exclusive receptor for the Tumor Necrosis Factor α (TNF-
α), it was shown that TNFR-1 interacts with the protein A of
S. aureus and may cause the release of cytokines, the apoptosis
of osteoblasts, or an unbalanced bone homeostasis (Claro et al.,
2011, 2013; Widaa et al., 2012).
It was proved that many signaling pathways are activated
in S. aureus-infected osteoblasts including ERK 1/2, JNK, c-
Jun, AP-1, Rip2 Kinase and NF-κB following the interaction
with PRRs or TNFR-1, (Ellington et al., 2001; Wright and
Friedland, 2002; Marriott et al., 2005; Ning et al., 2010; Claro
et al., 2013; Figure 2). S. aureus can virtually activate different
signaling pathways through either extracellular or intracellular
receptors. This combination of signaling mechanisms highlights
the diversity and the complexity of the osteoblast response to
various signals and/or bacterial infections.
IMPLICATION OF THE S.
AUREUS-CHALLENGED OSTEOBLASTS IN
THE IMMUNE RESPONSE
Following contact/internalization of S. aureus, the first line of
defense of the osteoblasts is to secrete inflammatory factors like
cytokines, chemokines and growth factors, all of which are able
to activate and recruit immune cells from the innate or adaptive
immune systems (Turner et al., 2014; Figure 3).
More specifically, the osteoblast production of IL-6, CCL2
(MCP-1), CCL3 (MIP-1α), and CCL5 (RANTES) increases
following S. aureus infection. These mediators are able to recruit
and activate macrophages (Bost et al., 1999, 2001; Ning et al.,
2011; Dapunt et al., 2014). An over-production of G-CSF and
GM-CSF—two growth factors that favor the maturation of
leukocytes—has also been demonstrated (Bost et al., 2000).
CXCL8 (IL-8) and CXCL2 (MIP-2α also called GRO-β)—two
neutrophil chemoattractants - are also up-regulated during
osteoblasts/S. aureus interaction (Wright and Friedland, 2002,
2004; Dapunt et al., 2014). Through releasing these mediators,
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TABLE 2 | In vitro consequences of Staphylococcus aureus/osteoblast interaction.
Cells Strains MOI Observations Author/Year
MNCOs, NHOs UAMS-1 25:1, 75:1,
250:1
Upregulation of expression and release of IL-6 and IL-12 in infected
osteoblasts
Bost et al., 1999
MNCOs, NHOs UAMS-1 25:1, 75:1,
250:1
Upregulation of expression and release of GM-CSF and G-CSF in
infected osteoblasts
Bost et al., 2000
MC3T3-E1 UAMS-1 250:1 Intracellular Staphylococcus aureus induces apoptosis of osteoblasts Tucker et al., 2000
MNCOs, NHOs UAMS-1 25:1, 75:1,
250:1
Induction of expression and release of TRAIL in infected osteoblasts Alexander et al.,
2001
MNCOs, NHOs UAMS-1 25:1, 75:1,
250:1
Upregulation of expression and release of MCP-1 in infected
osteoblasts, but not IL-3
Bost et al., 2001
MNCOs, NHOs UAMS-1, 25:1, 75:1,
250:1
Increase of phosphorylation of ERK 1 and 2 and activation of c-jun in
Staphylococcus aureus-infected osteoblasts
Ellington et al., 2001
MG-63, NHOs Clinic 10:1, 1:1 Upregulation of expression and release of IL-8, IP-10, RANTES, MCP-1
in infected osteoblasts
Wright and
Friedland, 2002
MNCOs, NHOs UAMS-1 75:1,
250:1
Upregulation of expression and release of IP-10 in infected osteoblasts Gasper et al., 2002
MNCOs, NHOs UAMS-1 25:1, 75:1,
250:1
Upregulation of expression of IL-1β and IL-18 in infected osteoblasts,
but no release of the related proteins in spite of the presence of
caspase I
Marriott et al., 2002
MNCOs, NHOs UAMS-1 25:1, 75:1,
250:1
Expression of TRAIL in infected osteoblasts induces apoptosis and
activation of caspase-8
Alexander et al.,
2003
MNCOs, NHOs UAMS-1 25:1, 75:1,
250:1
Upregulation of expression and production of CD40 in infected
osteoblasts and mediation of cytokine induction
Schrum et al.,
2003b
MNCOs, NHOs UAMS-1 25:1, 75:1,
250:1
Upregulation of mRNA and surface expression of MHC II in infected
osteoblasts
Schrum et al., 2003a
MNCOs Bacterial DNA - Induction of osteoclastogenesis by ligation of bacterial DNA upon
TLR-9 in osteoblasts
Zou et al., 2003
MG-63, NHOs Clinic 10:1, 1:1 Effect of Th2 cytokines, PGE2 and dexamethasone on release and
expression of RANTES, MCP-1, IP-10, IL-8 from infected osteoblasts
Wright and
Friedland, 2004
MNCOs UAMS-1 25:1, 75:1,
250:1
Stimulation of Nod1 and Nod2 by intracellular Staphylococcus aureus
and related cytokine release
Marriott et al., 2005
MNCOs, NHOs UAMS-1 125:1 Decrease of sensibility to antibiotics for intracellular established
Staphylococcus aureus
Ellington et al., 2006
MNCOs, NHOs UAMS-1, Lab 25:1, 75:1 Expression of TRAIL is observed in both infected and uninfected
osteoblasts in infected cultures
Reott et al., 2008
MNCOs, UAMS-1, Clinic 25:1, 75:1,
250:1
Upregulation of expression and production of RANK-L and production
of PGE2 via COX-2 activation in infected osteoblasts
Somayaji et al., 2008
hFOBs - Supernatant Up-regulation of the production of HBD-2 by osteoblasts challenged
with Staphylococcus aureus supernatants
Varoga et al., 2008
SaoS-2, NHOs - Supernatant Production of HBD-3 by osteoblasts via TLR2 after stimulation with
Staphylococcus aureus supernantant
Varoga et al., 2009
MNCOs UAMS-1 25:1, 75:1,
250:1
Modulation of osteoblast response to Staphylococcus aureus through
NOD2
Chauhan and
Marriott, 2010
SV40 hOBs UAMS-1 250:1 Release of MCP-1 and IL-6 in infected osteoblasts through NF-kB
regulation
Ning et al., 2010
SV40 hOBs UAMS-1 250:1 Necessity of attachment of Staphylococcus aureus to osteoblasts but
not internalization for activation of NF-kB
Ning et al., 2010
MNCOs, NHOs UAMS-1, Lab 25:1, 75:1,
250:1
Expression of TRAIL death receptors, DR4 and DR5, and decrease of
OPG production in infected osteoblasts
Young et al., 2011
MC3T3-E1 Lab - Induction of osteoblast apoptosis via Caspase-3 and expression of
RANK-L thanks to the binding of SpA from Staphylococcus aureus to
TNFR-1 of osteoblasts
Claro et al., 2011
MC3T3-E1 Lab - Inhibition of the osteoblast proliferation, induction of the migration of
pre-osteoclasts and osteoclastogenesis through SpA from
Staphylococcus aureus
Widaa et al., 2012
MC3T3-E1, SaoS-2 Clinic Supernatant Dose-dependent cytotoxicity of PSMα of Staphylococcus aureus on
osteoblasts
Cassat et al., 2013
(Continued)
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TABLE 2 | Continued
Cells Strains MOI Observations Author/Year
MC3T3-E1 Lab - SpA binds to TNFR-1 which activates NF-kB and the release of IL-6 Claro et al., 2013
MC3T3-E1 Lab 100:1 PVL, SpA and Coa of Staphylococcus aureus induce apotosis and
upregulate RANK-L expression in osteoblasts
Jin et al., 2013
MG-63 Lab, clinic 100:1 Killing effect of PSMα secreted by intracellular Staphylococcus aureus
on osteoblasts
Rasigade et al.,
2013
MC3T3-E1 Lab Supernatant Induction of production of MDB-14 (a murine ortholog HDB-3) by
Staphylococcus aureus-infected osteoblasts through MAPK and
NF-kB pathways
Zhu et al., 2013
NHOs UAMS-1, clinic Biofilm
supernatant
Decrease of osteoblast viability, inhibition of osteogenic differentiation
and increase of RANKL expression by osteoblasts by biofilm
components of Staphylococcus aureus
Sanchez et al., 2013
MC3T3-E1 Lab 100:1 Apoptosis and decrease of osteogenic differentiation in response to
Staphylococcus aureus through TLR2 expression and JNK activation
Chen et al., 2014
Primary osteoblasts Lab 20:1,
100:1,
500:1
Production of CCL2 and CXCL3 by osteoblasts following stimulation by
Staphylococcus aureus
Dapunt et al., 2014
MC3T3-E1 Lab 100:1 Expression of miR-24 was significantly down-regulated in
Staphylococcus aureus-infected osteoblasts compared with untreated
control cells. Overexpression of miR-24 could reduce the effects of
Staphylococcus aureus
Jin et al., 2015
MOI, Multiplicity of infection (number of bacteria per cell); MNCOs, Mouse neonate calvarial osteoblasts; NHOs, Normal human osteoblasts; MC3T3-E1, Mouse calvaria cell line; MG-63,
Human osteosarcoma cell line; SaoS-2, Human osteosarcoma cell line; hFOBs, Human fetal osteoblastic cell line; SV40 hOBs, Human osteoblastic cell line; Lab, Laboratory strains
of Staphylococcus aureus (purchased from ATCC, NCTC,. . . ); Clinic, Strain of Staphylococcus aureus isolated from osteomyelitic patients; UAMS-1, Most studied laboratory strain of
Staphylococcus aureus in bone infection models.
infected osteoblasts participate in the innate immune response in
an attempt to clear the bacteria.
Osteoblasts are furthermore deemed to take part in the
adaptive response to S. aureus. Infected osteoblasts up-regulate
their release of IL-12 and CXCL10 (IP-10)—two molecules
that recruit and activate Th1 lymphocyte—(Bost et al., 1999;
Gasper et al., 2002). S. aureus-challenged osteoblasts are also
able to express CD40 and MHC II, both implicated in the
initiation of Th1 lymphocyte response (Schrum et al., 2003a,b).
T lymphocytes secrete IFN-γ—a hallmark of their activation—
while interacting with S. aureus-infected osteoblasts (Bost et al.,
1999). There are no reports that confirm or exclude a role of other
adaptive immune cells such as Th17 lymphocytes or dendritic
cells in the response of osteoblasts to S. aureus. This needs to be
further investigated to figure out whether if osteoblasts have a real
role in adaptive immune responses in osteomyelitis or not.
An over-expression of TNF-α, IL-1β, and IL-18 mRNAs has
been proved but the related-protein release has not been observed
yet (Littlewood-Evans et al., 1997; Marriott et al., 2002), thus
we cannot assess the impact of S. aureus-infected osteoblasts on
inflammatory processes through these mediators. These findings
once combined suggest that osteoblasts infected by S. aureus
may participate in the innate immune response as well as in
the adaptive immune response likely through the initiation
of a Th1 lymphocyte response. This is sustained by current
studies focusing on the mutual interplay between immune and
bone systems designated as “osteoimmunology” (reviewed in
Takayanagi, 2007, 2015).
In vitro experiments were nonetheless mostly performed
using osteoblastic cell lines or marketed normal osteoblasts.
This may lead to an overstatement of the results, as such
models diverge from the in vivo pathophysiological scenario.
As described in Table 2, most of these results were obtained
from different in vitro studies, with various conditions of cell
culture or multiplicity of infection. The high multiplicities
of infection or long time periods are globally needed for a
release of cytokines/chemokines by osteoblasts. An increase
of mRNA expression happens 6 or 8 h after the interaction of
S. aureus with osteoblasts whereas the relative protein release
starts from 24 to 48 h after the interaction. Those results
justify the idea that inflammatory response by osteoblasts
should not be pivotal in osteomyelitis caused by S. aureus.
In addition, in vivo animal models of osteomyelitis showed
that professional immune cells are rapidly recruited after
infection (Yoshii et al., 2002; Horst et al., 2012; Niska
et al., 2012). Quantifying the release of mediators especially
produced by osteoblasts but not from recruited immune
cells appears to be a hard thing to do. These recruited
immune cells might likewise be more able to release large
amounts of IL-1β, IL-6 and, TNF-α than osteoblasts. Thinking
this through, we propose the osteal macrophages—also
called OsteoMacs—to act as the initiator of inflammation
in osteomyelitis. Those bone resident macrophages—which
are different from osteoclast precursors—are localized into
osteal tissue and play a role in both the bone formation
and bone reparation and bone-related diseases as previously
observed (Chang et al., 2008; Pettit et al., 2008). OsteoMacs
seem to be more likely to initiate an inflammatory response in
osteomyelitis than osteoblasts since they are professional resident
immune cells.
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FIGURE 3 | Staphylococcus aureus induction of inflammatory mediator production by osteoblasts and participation in the recruitment/activation of
innate and adaptive immune cells. Staphylococcus aureus interaction with osteoblasts increases the expression of cytokines IL-1β, IL-18, TNF-α, the production
and release of IL-6, IL-12 and the expression and release of chemokines CXCL2, CXCL8, CXCL10, CCL2, CCL3, CCL5 and growth factors G-CSF and GM-CSF. It
also increases the expression and production of CD40 and MHC II. All of this participates to the recruitment and activation of innate (neutrophils,
monocytes/macrophages) and adaptive (lymphocytes) immune cells.
S. AUREUS IMPACT ON OSTEOBLAST
ACTIVITY AND VIABILITY
S. aureus can also induce bone loss as well as a production of
inflammatory mediators from osteoblasts. This phenomenon is
partially due to a decrease of osteoblast activity and to their
death following bacterial insult. S. aureus is known to inhibit
osteoblast activity and differentiation. Several studies have shown
a decrease of proliferation, a decreased alkaline phosphatase
activity, and a lower expression of BEM components such as type
I collagen, osteocalcin, osteopontin, and osteonectin in in vitro
models of S. aureus/osteoblast interaction (Claro et al., 2011;
Widaa et al., 2012; Jin et al., 2013). S. aureus is also known to
prevent the mineralization process, observed through a lower
calcium deposition in infected osteoblast cultures compared to
their non-infected counterparts (Claro et al., 2011; Jin et al., 2013;
Sanchez et al., 2013; Chen et al., 2014).
Controversies arose from Somayaji et al. work in which they
have figured out that UV-killed S. aureus coated on titanium
alloys favored osteoblast adhesion, osteoblast differentiation and
mineralization (Somayaji et al., 2010). These results in opposition
with all the previous statements suggest that the effect of S. aureus
on osteoblast activity is not totally elucidated. Jin et al. recently
highlighted that effects of S. aureus on osteoblast activity could be
dependent of microRNAs (Jin et al., 2015). Relationship between
osteoblast response to S. aureus and the microRNAs production
could be a new interesting approach to understand osteomyelitis
at a cellular level and decipher which components are able to
whether decrease or increase osteoblastic activity.
S. aureus can also cause apoptosis of osteoblasts regardless
to specific osteoblastic activity. This is observed following S.
aureus infection of various cell types including endothelial cells,
epithelial cells or osteoblasts (Menzies and Kourteva, 1998;
Kahl et al., 2000; Tucker et al., 2000). In S. aureus-infected
osteoblasts, apoptosis appeared to be dependent on the release
of the tumor necrosis factor-related apoptosis-inducing ligand
(TRAIL; Alexander et al., 2001). TRAIL interacts with death
receptors DR4 and DR5 expressed in infected osteoblasts (Young
et al., 2011), leading to the induction of apoptotic pathways.
In the situation of S. aureus-infected osteoblasts, an activation
of the apoptosis intrinsic pathway through caspase-9 (Jin et al.,
2013) and the extrinsic pathway through caspase-8 was observed
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(Alexander et al., 2003), both of them leading to activation of
caspase-3 and apoptosis (Claro et al., 2011; Figure 4).
Osteoblast death was also associated with above-cited toxins
produced by S. aureus like PSMα, PSMβ, and δ-toxin (Cassat
et al., 2013; Rasigade et al., 2013; Valour et al., 2015b). These
virulence factors have a membrane-damaging activity which
suggests that S. aureus-induced osteoblast death can also be
independent of apoptosis. Non-apoptotic cell death has been
observed in presence of α-toxin—another membrane-damaging
virulence factor of S. aureus—in an in vitro cell line model
(Essmann et al., 2003).
Death induction in osteoblasts is an important feature of S.
aureus-related osteomyelitis. On the one hand, it leads to lowered
bone formation activity and on the other hand, the death of
osteoblasts may allow the release of the intracellular viable S.
aureus, which are able to re-infect surviving osteoblasts and
exacerbate the infection (Ellington et al., 2003).
S. AUREUS/OSTEOBLASTS INTERACTION
AND OSTEOCLASTOGENESIS
Bone loss in osteomyelitis is also caused by an increased
formation and activation of osteoclasts in addition to the death
of osteoblasts. A tight balance between bone formation by
osteoblasts and bone resorption by osteoclasts is essential for
the strength and integrity of bones. We have so far reviewed a
role of S. aureus in decreasing osteoblast activity and inducing
osteoblast death, hinting an impaired osteoblast/osteoclast
balance necessary for proper bone formation.
Osteoblasts are producers of receptor activator of NF-
κB ligand (RANK-L) and osteoprotegerin (OPG). RANK-L
interacts with its receptor RANK on monocyte/macrophage
precursors to drive their differentiation toward osteoclasts.
OPG is a soluble decoy receptor that targets RANK-L to
limit osteoclastogenesis (Boyle et al., 2003). In the case of
S. aureus infection, osteoblasts increase their production of
membrane-bound RANK-L and sRANK-L—a soluble and minor
form of RANK-L—whereas OPG production by osteoblasts
decreases following S. aureus infection despite an absence of
modulation of the OPG mRNA synthesis (Somayaji et al.,
2008; Claro et al., 2011; Young et al., 2011; Widaa et al.,
2012; Figure 5). It is therefore thought that S. aureus is
able to indirectly increase osteoclastogenesis as a result of its
interaction with osteoblasts. An increase of prostaglandin E2
(PGE2) production has furthermore been demonstrated in S.
aureus-infected osteoblasts (Somayaji et al., 2008). PGE2—a
hormone-like molecule and enzymatic product of the cyclo-
oxygenase 2 (Cox-2)—acts in an autocrine and paracrine manner
to upregulate the production of RANK-L through activation of
FIGURE 4 | Staphylococcus aureus induction of osteoblast death. Staphylococcus aureus can cause the necrosis of osteoblasts through the release of
membrane-damaging virulence factors such as PSMs. It can also induce the apoptosis of osteoblasts through intrinsic and extrinsic caspase pathways. Both can lead
to the release of intracellular Staphylococcus aureus, which can re-infect other osteoblasts.
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FIGURE 5 | Induction of osteoclastogenesis by Staphylococcus aureus-challenged osteoblasts. S. aureus-challenged osteoblasts increase their expression
and production of RANK-L, directly or through the COX-2/PGE2 pathway. It leads to an excessive formation and activation of osteoclasts and to a severe bone
resorption in addition to a decreased production of OPG.
the EP4 receptor in osteoblasts (Figure 5). PGE2 up-regulated
by S. aureus thus acts as a complementary stimulating effect
on osteoblasts to release osteoclastogenic factors (Johansen
et al., 2012). Recent studies nevertheless showed that S. aureus
or its components can also favor bone resorption through
interaction with osteoclast cell lineage. S. aureus provoked the
enhancement of the osteoclast differentiation and the release of
pro-inflammatory cytokines (Kim et al., 2013). These cytokines
enhanced the bone resorption capacity of uninfected mature
osteoclasts and promoted osteoclastogenesis of the uninfected
precursors (Trouillet-Assant et al., 2015). Further studies are
yet needed to fully fathom the interactions between S. aureus
and osteoclasts and the mechanisms involved in the latter
interactions.
OSTEOBLAST SELF-DEFENSE AGAINST S.
AUREUS
Infected osteoblasts can release AMPs in order to defend
themselves against S. aureus. These molecules, mostly cationic,
are secreted by various types of cells and are able to neutralize
bacteria. They are classified in three categories: α-defensins, β-
defensins and cathelicidin-related molecules—with LL-37 as the
only member in humans—(reviewed in Mansour et al., 2014).
It was shown that human osteoblasts increase their release of
human β-defensin (HBD) 2 and HBD-3 following stimulation
by S. aureus culture supernatants, (Varoga et al., 2008, 2009).
The release of MBD-14—the murine ortholog of HBD-3—was
also seen in infected murine osteoblasts (Zhu et al., 2013). A
higher expression of HBD-3 and MBD-14 was also found in
human interfacial membrane surrounding implants infected by
S. aureus and in a murine model of osteomyelitis, respectively
(Zhu et al., 2014). LL-37 is moreover secreted by the human
bone marrow mesenchymal stem cells (Krasnodembskaya et al.,
2010) and described to exhibit a killing effect on S. aureus
inside osteoblasts (Noore et al., 2013). The use of exogenous
LL-37 in osteomyelitis is however uncertain as it might have
deleterious effects on osteoblasts (Säll et al., 2013; Svensson et al.,
2015). As for α-defensins, their production is mostly attributed
to neutrophils or Paneth cells, and not to osteoblasts or other
stromal cells (Mansour et al., 2014). The use of exogenous AMPs
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could be a promising and effective way to treat osteomyelitis.
Synthetic compounds similar to AMPs were produced and
relevant as treatments toward bacterial infection, and notably
in a S. aureus infection model (Nijnik et al., 2010). They can
be added by the way to supports like titanium alloys, thus
enlarging their possible use to fight against implant-associated
osteomyelitis (Kazemzadeh-Narbat et al., 2013). Up to now, the
emergence of resistance to AMPs was considered low, virtually
because of the complexity of their mode of action (Jenssen et al.,
2006). A recent review however highlights that S. aureus holds
mechanisms of resistance to AMPs (Joo and Otto, 2015). As
a matter of fact, we deem this moderates the brilliant future
for AMPs in anti-staphylococcal treatments be it in bone or
elsewhere.
ANTIBIOTIC CHEMOTHERAPIES AT S.
AUREUS/OSTEOBLASTS SPECIFIC SCALE
Clinical guidelines for the treatment of osteomyelitis with S.
aureus generally recommend the use of a combination of
antibiotics consisting of penicillin M—i.e., oxacillin—combined
with an aminoglycoside—i.e., gentamicin—or to rifampicin. The
uses of glycopeptide—i.e., vancomycin—combined with linezolid
or rifampicin, of clindamycin combined with rifampicin, or of
fluoroquinolone—i.e., ofloxacin—combined with rifampicin are
considerable options for the treatment of osteomyelitis with
meticillin-resistant S. aureus (MRSA; Lew and Waldvogel, 2004;
Hatzenbuehler and Pulling, 2011; Osmon et al., 2013; Lima et al.,
2014).
The internalization of S. aureus inside osteoblasts however
represents a major challenge in the treatment of osteomyelitis.
The ability of the recommended antibiotics to kill intracellular S.
aureus is the cornerstone for relevant treatment of osteomyelitis.
In this context, studies have assessed the effects of these
antibiotics in in vitro models of infection. A treatment with
gentamicin, vancomycin or daptomycin decrease the number
of intra-osteoblastic bacteria, without totally eradicating them,
even at high concentrations. The rifampicin used in clinical
concentrations has on the contrary resulted to eradicate
intracellular S. aureus inside cultured osteoblasts (Mohamed
et al., 2014; Valour et al., 2015a). The treatment has to start but
very early since a 12 h-delayed rifampicin treatment of S. aureus-
challenged osteoblasts significantly decreased its effectiveness
in killing intracellular bacteria by 100-fold (Ellington et al.,
2006). In this case, the surface of S. aureus is altered
after exposure to the intracellular osteoblast environment
as Ellington et al. described it. A thick capsular material
appears on intra-osteoblastic S. aureus that could explain the
resistance to rifampicin. Specific mechanisms that describe the
alteration of the surface of S. aureus by osteoblast intracellular
environment have not been determined yet but we can
suggest that SCVs may be involved in this phenomenon.
One can say that further investigations need to be carried
out. Combined therapy using rifampicin and ultrasound has
been recently proposed to enhance the intracellular killing
relevancy but it seemed that ultrasounds had a negative impact
on the viability of cultured osteoblasts (Shi et al., 2013).
This process is even more difficult to transpose to clinical
applications.
Recent studies investigated the effect of tigecyclin, teicoplanin,
ofloxacin, and linezolid. These antibiotics—which are
recommended in the treatment of osteomyelitis—have an
intermediate intracellular antimicrobial effectiveness, higher
than gentamicin or vancomycin and lower or equivalent to
rifampicin (Kreis et al., 2013; Valour et al., 2015a). Ofloxacin,
daptomycin, and vancomycin were also deemed to limit
intracellular SCVs emergence (Valour et al., 2015a). The
concentration however used in antibiotic treatment is also
a critical point. Sub-inhibitory concentrations of oxacillin,
moxifloxacin, and linozelid increase the fibronectin-mediated
binding of S. aureus whereas sub-inhibitory concentrations
of rifampicin still have decreasing effects on its binding
(Rasigade et al., 2011). Radezolid and naficillin-loaded
nanoparticles have also been investigated for their ability to
kill S. aureus inside cultured osteoblasts (Pillai et al., 2008;
Lemaire et al., 2010). Radezolid has shown a higher bactericidal
activity compared to linezolid and an effective killing of
intracellular bacteria was observed with naficillin-loaded
nanoparticles.
All these recent studies shed light on the importance of intra-
osteoblastic penetrance of antibiotics. This property is essential
for the development of new therapeutics against osteomyelitis
caused by S. aureus.
CONCLUSION
Osteoblast infection by S. aureus can be defined as a 4-
step process from mostly in vitro models. First, S. aureus
binds to the BEM and to osteoblasts. Through attachment,
S. aureus can be internalized and survive within the cell
switching notably to a SCV phenotype. Then, S. aureus or
its components may potentially modulate the production of
cytokines, chemokines or AMPs, through binding to extracellular
and/or intracellular receptors. Infection with S. aureus eventually
induces inflammatory cell recruitment, which, combined with
increased osteoclastogenesis and osteoblast death, leads to a
massive bone loss (Figure 6).
Nevertheless, the defined role of infected osteoblasts in
inflammatory response results from in vitro experiments that
were mostly done with osteoblastic cell lines or marketed
normal osteoblasts (Table 2) and diverges from the in vivo
pathophysiological scenario. Cytokines/chemokines released by
infected osteoblasts must only be a drop in the bucket compared
to those released by neutrophils and macrophages/monocytes
during osteomyelitis caused by S. aureus. From this point of view,
osteoblasts thought to take part in global inflammatory response
but without having a decisive role.
On the other side, internalization and intracellular persistence
appears to us as the key stages of S. aureus/osteoblast interaction.
Escape from intra-osteoblastic vesicle, switching to a SCV
phenotype and osteoblast death following membrane damages
are important phenomena to understand the evolution from
acute to chronic osteomyelitis.
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FIGURE 6 | Summary diagram of the osteoblasts responses in presence of Staphylococcus aureus. S. aureus can interact with osteoblasts and provoke:
inflammation by increased release of mediators such as cytokines (CTKs), chemokines (CMKs), or growth factors (GFs); osteoblast self-defense by the production of
AMPs (HBD-2/3, LL-37); osteoblasts death through apoptosis or necrosis; bone resorption by activation of the RANK/RANK-L complex.
The S. aureus infection of the osteoblast is in the end a
very complex phenomenon with a myriad of actors (Figure 6).
To focus on one specific step allows us to better understand
a precise mechanism but does not reflect the complexity of
the entire infectious process, in the same way that focusing
only on osteoblasts and avoiding other cells from bone
tissues limits and biases our understanding. The use of new
research models is necessary to complete the information
obtained from the previous osteoblast in vitro infection
models.
It is clear to us that more investigations using patient isolated
S. aureus/primary osteoblasts in vitro models are needed and
that systemic in vivo models close to the human scenarios of
infection need to be optimized to consider new therapeutic
approaches for this disease of high morbidity. New treatments
or preventive approaches need also to be developed so as to
avoid the internalization of S. aureus inside osteoblasts, contain
the local inflammatory process, and increase the osteoblasts self-
defense.
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